Quantitative measurement of CA 15-3 cancer biomarker using an electrochemical aptasensor based on the electrodeposition of Au thin film on cauliflower-like rGO-MoS2 nanocomposite

• Published in: Mikrochimica acta (1966) Vol. 190; no. 10; p. 406
• Main Authors: Vojgani, Yasaman, Ranjbar, Saba, Naseri, Naimeh, Dolati, Abolghasem, Madjd, Zahra, Kiani, Jafar, Saeedi, Sara, Karimi, Mahdi
• Format: Journal Article
• Language: English
• Published: Vienna Springer Vienna 01-10-2023; Springer Nature B.V
• Subjects: Analytical Chemistry; Antigens; Biomarkers; Breast cancer; Carbohydrates; Characterization and Evaluation of Materials; Charge transfer; Chemistry; Chemistry and Materials Science; Electrochemical impedance spectroscopy; Electrodeposition; Gold; Graphene; Microengineering; Molybdenum disulfide; Nanochemistry; Nanocomposites; Nanotechnology; Original Paper; Thin films; Modified electrode; Reduced graphene oxide-molybdenum sulfide nanocomposite; Gold nanoparticles; CA 15-3 antigen; Breast cancer; Aptasensor; Electrochemical impedance spectroscopy
• ISSN: 0026-3672; 1436-5073
• DOI: 10.1007/s00604-023-05989-4

The present research was conducted to design and construct an electrochemical aptasensor for evaluating carbohydrate antigen 15-3 (CA15-3) as a biomarker for breast cancer. The aptasensor has been fabricated by a gold thin film (AuTF) electrodeposited on a cauliflower-like reduced graphene oxide-molybdenum sulfide nanocomposite (rGO-MoS
2
). The modified electrode’s surface was used to immobilize the thiolated aptamer, which was subsequently treated with CA 15-3 antigen. The aptasensor fabrication process was assessed using electrochemical impedance spectroscopy (EIS) and cyclic voltammetry (CV). This research also applied EIS to the quantitative measurement of CA 15-3 antigen by the proposed aptasensor. The interfacial charge transfer resistance (
R
ct
) alteration before and after incubation of CA 15-3 by the immobilized aptamer was considered a signal for the quantitative measurement of CA 15-3. A linear concentration ranging from 5.0 to 200.0 U mL
−1
with a detection limit of 3.0 × 10
−1
U mL
−1
was obtained for CA 15-3 using the EIS method. This designed aptasensor indicates satisfactory repeatability and stability, good selectivity, and high sensitivity. Moreover, clinical samples were assayed by the prepared aptasensor and compared with the ELISA method, yielding acceptable results. The recovery and relative standard deviation (RSD) of CA 15-3 in human serum samples were in the range 95.0 to 107.0% and 3.5 to 7.5%, respectively.
Graphical abstract